MedPath

Prospective Validation of a Pre-Specified Algorithm for the Management of Conduction Disturbances Following TAVR

Recruiting
Conditions
Conduction Disturbances
Transcatheter Aortic Valve Replacement
Permanent Pacemaker Implantation
Registration Number
NCT04139616
Lead Sponsor
Centre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Quebec
Brief Summary

The high incidence and variety of conduction disturbances post-TAVR represents a major challenge in the periprocedural management of TAVR recipients. Despite the growing body of knowledge on this topic, the large variability in the management of these complications has translated into a high degree of uncertainty regarding the most appropriate treatment of a large proportion of such patients. The implementation of a pre-specified treatment strategy translating into a more uniform practice regarding the management of conduction disturbances post-TAVR applied to a large cohort of patients would permit to identify the benefits and drawbacks of each specific aspect of the treatment algorithm proposal. This may also help to improve both the management and clinical outcomes of the complex group of patients with conduction disturbances associated with TAVR. In the end, the final objective of a pre-specified strategy for managing conduction disturbances post-TAVR should be to obtain a low rate of PPM without increasing the risk of sudden death or life threatening arrhythmic events following hospital discharge, and all this while avoiding an excessive prolongation of the hospitalization period following the TAVR procedure.

Detailed Description

The objectives of the study are:

* Feasibility: to validate and determine the applicability of a pre-specified algorithm for managing conduction disturbances in consecutive patients undergoing TAVR, also evaluating the percentage of patients included in each group of the algorithm strategy.

* Efficacy: (i) to evaluate the rate of permanent pacemaker implantation in-hospital and at 30 days compared to that of the year prior to the implementation of the protocol, (ii) to determine the incidence of sudden death at 30 days and at 1-year follow-up.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
2000
Inclusion Criteria

-Patients with aortic valve disease undergoing transcatheter aortic valve replacement

Exclusion Criteria
  • Prior permanent pacemaker
  • Failure to provide signed informed consent for data collection
  • Impossibility for a follow-up
  • Unwillingness to follow the pre-specified strategy for the management of conduction disturbances

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Rate of successful algorithm implementation and percentage of patients in each arm of the pre-specified algorithm1 year follow-up
Incidence of permanent pacemaker implantationAt 1-year follow-up
Incidence of sudden deathAt 1-year follow-up
Secondary Outcome Measures
NameTimeMethod
Rate and timing of sudden deathAt 1-year follow-up

Rate and timing of sudden death in each group of the pre-specified algorithm

Factors associated with sudden death or permanent pacemaker implantationAt 1-year follow-up

Determine factors associated with sudden death or permanent pacemaker implantation during the follow-up period overall and in each algorithm group

Evaluation of the rate and timing of permanent pacemaker implantationAfter hospital discharge (up to 1-year)
Evaluation of arrhythmic events in patients with continuous ECG monitoringAfter hospital discharge (up to 1-year)

Evaluation of arrhythmic events in patients with continuous ECG monitoring at hospital discharge

Rate of PPI among valve typesAt 1-year follow-up

Compare rate of permanent pacemaker implantation among different valve types

Pace dependency and pacing rateAt 1-year follow-up

Determine the pace dependency and pacing rate in patients with periprocedural permanent pacemaker implantation (overall and in each subgroup of the algorithm)

Rate, timing of and reasons for permanent pacemaker implantationAt 1 year follow-up

Rate, timing of and reasons for permanent pacemaker implantation in each group of the pre-specified algorithm

Trial Locations

Locations (1)

IUCPQ

🇨🇦

Quebec, Canada

© Copyright 2025. All Rights Reserved by MedPath